| Abstract | The case of a seven-year-old boy with chronic pruritus secondary to a giant congenital melanocytic nevus is presented. The pruritus did not respond to conventional antipruritic drug treatment, but responded to ondansetron, a selective antagonist of 5-hydroxytryptamine type 3 receptors. |
| Authors | Chantal Frigon, Joëlle Desparmet
(Affiliation: Chronic Pain Clinic, Department of Anesthesia, The Montreal Children's Hospital, Montreal, Quebec, Canada. chantal.frigon at muhc.mcgill.ca)
|
| Journal | Pain research & management : the journal of the Canadian Pain Society = journal de la société canadienne pour le traitement de la douleur
(Pain Res Manag)
Vol. 11
Issue 4
Pg. 245-7
( 2006)
ISSN: 1203-6765 Canada |
| PMID | 17149457
(Publication Type: Case Reports, Journal Article)
|
| Chemical References |
- Antipruritics
- Ondansetron
|
| Topics |
- Antipruritics
(therapeutic use)
- Child
- Chronic Disease
- Humans
- Male
- Ondansetron
(therapeutic use)
- Pruritus
(drug therapy)
|
